Universitaetsklinikum Brandenburg an der Havel GmbH

The Department of Gastroenterology and Hepatology at Universitaetsklinikum Brandenburg an der Havel GmbH is involved in clinical trials focused on digestive system diseases and related physiological phenomena. The studies mainly explore Crohn’s disease, ulcerative colitis, eosinophilic esophagitis, gastroparesis, and liver cirrhosis, with the goal of improving symptom control, remission rates, and long-term disease management.

• Testing new therapies for inflammatory bowel disease, especially Crohn’s disease and ulcerative colitis
• Evaluating treatments for eosinophilic esophagitis and other upper digestive tract disorders
• Studying approaches to relieve symptoms and improve quality of life in gastroparesis and liver cirrhosis

Across these studies, the site contributes to research on both new medicines and better treatment strategies for chronic digestive illnesses.

The site is also active in cardiovascular disease trials, including research in acute coronary syndrome, established cardiovascular disease, hypertension, and prevention of heart failure. These studies are designed to reduce major heart and vascular events and to improve long-term protection for patients at elevated risk.

• Assessing new treatments to lower the risk of heart attack, stroke, and cardiovascular death
• Exploring options for patients with high cardiovascular risk and hypertension
• Evaluating therapies aimed at preventing heart failure and related complications

These trials reflect a strong focus on better prevention and outcome improvement in common and serious cardiovascular conditions.

Clinical research at this hospital includes trials in neoplasms, with studies involving mantle cell lymphoma, early breast cancer, advanced ovarian cancer, and esophageal adenocarcinoma. The work is centered on improving cancer control, supporting organ-preserving treatment options, and evaluating more effective treatment combinations.

• Testing new approaches for lymphoma and blood cancer treatment
• Studying treatment strategies for breast cancer and ovarian cancer
• Assessing cancer care options that may improve response and reduce the need for invasive procedures

These oncology studies broaden the site’s research profile beyond digestive and heart disease, supporting advances in several major cancer types.

Research at the Universitaetsklinikum Brandenburg an der Havel GmbH also covers digestive system and oral physiological phenomena, with attention to how digestive disorders affect function, inflammation, and healing. Trials in this area focus on measuring disease activity and confirming whether new treatments can improve tissue health and clinical remission.

• Investigating histological remission and inflammatory improvement in eosinophilic esophagitis
• Evaluating response measures in ulcerative colitis and Crohn’s disease
• Studying treatment effects on digestive symptoms and underlying disease activity

This area highlights the site’s interest in both the biological and clinical aspects of gastrointestinal disease, helping refine how treatment success is understood.